Dr Scott Gottlieb M.D

Former U.S. Food and Drug Administration Commissioner

Biography

Scott Gottlieb, MD served as the 23rd Commissioner of the U.S. Food and Drug Administration from 2017 to 2019. Dr. Gottlieb is a physician, medical policy expert, and public health advocate who previously served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and before that, as a senior advisor to the FDA Commissioner. He also worked on implementation of the Medicare drug benefit as a senior advisor to the Administrator of the Centers for Medicare and Medicaid Services, where he supported policy work on quality improvement and the agency’s coverage process, particularly as it related to new medical technologies.

Dr. Gottlieb is an elected member of the National Academy of Medicine and currently serves on the executive committee of the Mount Sinai Health System’s board of directors and co-chairs the board’s education committee. Dr Gottlieb is the author of the New York Times bestselling book “Uncontrolled Spread: Why Covid-19 Crushed Us and How We Can Defeat the Next Pandemic” and is a regular contributor to CNBC and CBS News’ Face the Nation.

Dr Gottlieb currently serves as a director of the publicly traded companies Pfizer, Inc. and TempusAI, and has recently been elected the non-executive Chair of Illumina.  He is a Partner at the venture capital firm New Enterprise Associates and a Senior Fellow at the American Enterprise Institute for Public Policy Research